These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25286559)

  • 21. Charting new frontiers in interventional medicine.
    Fajadet J
    EuroIntervention; 2013 May; 9 Suppl R():R10-1. PubMed ID: 23732138
    [No Abstract]   [Full Text] [Related]  

  • 22. [Renal artery denervation for treating refractory hypertension].
    Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
    Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.
    Mahfoud F; Schlaich M; Kindermann I; Ukena C; Cremers B; Brandt MC; Hoppe UC; Vonend O; Rump LC; Sobotka PA; Krum H; Esler M; Böhm M
    Circulation; 2011 May; 123(18):1940-6. PubMed ID: 21518978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon.
    Bunte MC; Infante de Oliveira E; Shishehbor MH
    JACC Cardiovasc Interv; 2013 Jan; 6(1):1-9. PubMed ID: 23266234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventional therapy for hypertension: Back on track again?
    Erne P; Sudano I; Resink TJ; Lüscher TF
    Crit Rev Clin Lab Sci; 2017 Jan; 54(1):18-25. PubMed ID: 27282628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
    Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypertension and the sympathetic nervous system - recent developments in research and treatment].
    Grisk O
    Dtsch Med Wochenschr; 2009 Nov; 134(45):2289-93. PubMed ID: 19876804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal sympathetic denervation in hypertension.
    Doumas M; Faselis C; Papademetriou V
    Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):647-53. PubMed ID: 21885968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interventional renal sympathetic denervation - a new approach for patients with resistant hypertension].
    Mahfoud F; Böhm M
    Dtsch Med Wochenschr; 2010 Dec; 135(48):2422-5. PubMed ID: 21108158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension.
    Ahmed H; Neuzil P; Skoda J; Petru J; Sediva L; Schejbalova M; Reddy VY
    JACC Cardiovasc Interv; 2012 Jul; 5(7):758-65. PubMed ID: 22814781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Salt sensitivity in patients with arterial hypertension].
    Babkin AP; Gladkikh VV; Pershukov IV
    Kardiologiia; 2010; 50(9):57-62. PubMed ID: 21118168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal denervation in the treatment of hypertension].
    Tikkanen I; Lappalainen K
    Duodecim; 2013; 129(8):825-32. PubMed ID: 23720950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Baroreflex in Hypertension.
    Fernandez G; Lee JA; Liu LC; Gassler JP
    Curr Hypertens Rep; 2015 Mar; 17(3):19. PubMed ID: 25754323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited.
    Tam GM; Yan BP; Shetty SV; Lam YY
    Int J Cardiol; 2013 Apr; 164(3):277-81. PubMed ID: 22336259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension.
    Navar LG
    J Appl Physiol (1985); 2010 Dec; 109(6):1998-2000; discussion 2015. PubMed ID: 21148349
    [No Abstract]   [Full Text] [Related]  

  • 37. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Systemic hypertension--involvement of the CNS to this complex puzzle.
    Moreira TS; Takakura AC; Antunes VR
    J Appl Physiol (1985); 2010 Dec; 109(6):2004. PubMed ID: 21188814
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal denervation for treatment-resistant hypertension.
    Mafeld S; Vasdev N; Haslam P
    Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):245-58. PubMed ID: 23132232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal denervation: transition from pathophysiology to clinical practice.
    Gossios TD; Ziakas A; Doumas M; Katsiki N; Petroglou D; Kouparanis A; Lillis L; Karvounis H
    Angiology; 2014 Oct; 65(9):760-8. PubMed ID: 24402321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
    Hering D; Esler MD; Schlaich MP
    EuroIntervention; 2013 May; 9 Suppl R():R127-35. PubMed ID: 23732145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.